Piperazinyl-containing indole derivatives, and preparation method and application thereof

A technology of indole and alkyl, applied in the field of indole derivatives containing piperazinyl and its preparation and application

Active Publication Date: 2016-08-17
SHENYANG PHARMA UNIVERSITY
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But clinically used tamoxifen and raloxifene can cause adverse reactions such as endometrial cancer and hot flashes (Fisher B, CostantinoJP, Wickerham DL, et al.J Nati Cancer Inst, 1998,90:1371-1388 ; Walsh BW, Kuller LH, Wild RA, et al. J Am Med Assoc, 1998, 279:1445-1451)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Piperazinyl-containing indole derivatives, and preparation method and application thereof
  • Piperazinyl-containing indole derivatives, and preparation method and application thereof
  • Piperazinyl-containing indole derivatives, and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] Example 1: Preparation of 1-[4-(4-methylpiperazin-1-yl)butyl]-5-hydroxyl-2-(4-hydroxyphenyl)-3-methyl-1H-indole

[0034] Step A): Preparation of 1-(4-benzyloxyphenyl)-2-(4-benzyloxyphenylamino)-1-propanone

[0035] Place 4-benzyloxyaniline (7.8g, 0.039mol), 1-(4-benzyloxyphenyl)-2-bromo-1-propanone (10.5g, 0.033mol) in a 500mL round bottom flask, ethanol As a solvent, triethylamine (6.6g, 0.065mol) was added, and the reaction was refluxed for 5h. Naturally cooled to room temperature, and suction filtered to obtain 12.3 g of a milky white solid with a yield of 85.3%. m.p.125-126°C. ESI-MS: m / z 438 ([M+H] + ).

[0036] Step B): Preparation of 5-benzyloxy-2-(4-benzyloxyphenyl)-3-methyl-1H-indole

[0037] 1-(4-benzyloxyphenyl)-2-(4-benzyloxyphenylamino)-1-propanone (12.3g, 0.028mol), 4-benzyloxyaniline (14.0g, 0.070mol) Place in a 500mL flask, use ethylene glycol monoethyl ether as a solvent, and reflux for 6 hours. The solvent was evaporated under reduced pressure, ...

Embodiment 2

[0042] Example 2: Preparation of 1-[4-(4-ethylpiperazin-1-yl)butyl]-5-hydroxyl-2-(4-hydroxyphenyl)-3-methyl-1H-indole

[0043] According to the method of Example 1, 0.31 g of a yellow solid was obtained with a yield of 36.7%. m.p.106-107°C. ESI-MS: m / z 408 ([M+H] + ). 1 H-NMR (400MHz, DMSO-d 6 )δ8.53(s,1H),7.96(s,1H),7.23(d,J=8.7Hz,1H),7.17(d,J=8.6Hz,2H),6.89(d,J=8.5Hz, 2H), 6.77(d, J=2.2Hz, 1H), 6.64(dd, J=8.4, 1.9Hz, 1H), 4.22(t, J=6.6Hz, 2H), 3.95(t, J=7.1Hz, 2H),3.62(m,2H),3.47(m,2H),2.98(m,2H),2.67(m,2H),2.18(m,2H),2.04(s,3H),1.62(m,4H ), 1.06 (t, J=5.6Hz, 3H).

Embodiment 3

[0044] Example 3: Preparation of 1-[4-(piperazin-1-yl)butyl]-5-hydroxyl-2-(4-hydroxyphenyl)-3-methyl-1H-indole

[0045] According to the method of Example 1, 0.32 g of an orange solid was obtained, with a yield of 41.9%. m.p.155-156°C. ESI-MS: m / z 380 ([M+H] + ). 1 H-NMR (400MHz, DMSO-d 6 )δ9.78(s,1H),8.52(s,1H),7.23(d,J=8.7Hz,1H),7.17(d,J=8.6Hz,2H),6.89(d,J=8.5Hz, 2H), 6.77(d, J=2.2Hz, 1H), 6.64(dd, J 1 =8.7Hz,J 2 =2.2Hz,1H),4.22(t,J=6.6Hz,2H),3.95(m,2H),3.64(m,2H),3.47(m,2H),2.98(m,2H),2.39(s , 1H), 2.18(t, J=7.1Hz, 2H), 2.04(s, 3H), 1.07(m, 4H).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the technical field of medicine, and relates to piperazinyl-containing indole derivatives and medical application thereof. The phenyl indole derivatives comprise stereomers and pharmaceutically applicable salts of the compounds, and the structural general formula is disclosed in the specification. The piperazinyl-containing indole derivatives and pharmaceutically applicable acid-added salts of the compounds can be mixed with the existing drug or independently used as an estrogen receptor regulator for treating or preventing various estrogen-function-related diseases, such as bone loss, fracture, osteoporosis, hectic fever, LDL cholesterol level increase, cardiovascular diseases, cognitive impairment, brain degeneration diseases, anxiety, depression caused by deficiency of estrogen, sexual disorder, hypertension, retinosis and cancer, and especially osteoporosis.

Description

technical field [0001] The invention relates to indole derivatives containing piperazinyl groups, their preparation methods, and their application in the preparation of estrogen receptor modulator medicines. Background technique [0002] Compounds that mimic estrogen-like effects have a wide range of therapeutic and prophylactic applications, including: treatment of osteoporosis, relief of menopausal symptoms, treatment of acne, treatment of dysmenorrhea and dysfunctional uterine bleeding, prostate cancer and prevention of cardiovascular disease. [0003] Studies have found that there are two types of estrogen receptors (ER): ERα and ERβ. After the ligand binds to these two isoforms, it exerts physiological effects with different tissue specificities. [0004] What is needed in the art is a compound that can produce a positive response like estrogen replacement therapy but without adverse side effects or with reduced side effects, and exert tissue-specific estrogen-like eff...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D209/12A61K31/496A61P5/30A61P19/10A61P19/08A61P15/14A61P15/00A61P13/08A61P35/00
CPCC07D209/12
Inventor 胡春左莉滕雨刘晓平黄二芳金辄
Owner SHENYANG PHARMA UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap